Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $585,060 of Shares

- By insider

CEO of Biomarin Pharmaceutical Inc (30-Year Financial, Insider Trades) Jean Jacques Bienaime (insider trades) sold 7,000 shares of BMRN on 02/19/2021 at an average price of $83.58 a share. The total sale was $585,060.

• Warning! GuruFocus has detected 4 Warning Signs with BMRN. Click here to check it out.

• BMRN 15-Year Financial Data

• The intrinsic value of BMRN

• Peter Lynch Chart of BMRN

Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions. Biomarin Pharmaceutical Inc has a market cap of $14.71 billion; its shares were traded at around $81.060000 with a P/E ratio of 18.54 and P/S ratio of 8.11. GuruFocus has detected 2 severe warning signs with Biomarin Pharmaceutical Inc. .

CEO Recent Trades:

• CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 02/19/2021 at the average price of $83.58. The price of the stock has decreased by 3.02% since.

• CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 02/18/2021 at the average price of $85.08. The price of the stock has decreased by 4.72% since.

• CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 02/17/2021 at the average price of $84.54. The price of the stock has decreased by 4.12% since.

• CEO Jean Jacques Bienaime sold 16,667 shares of BMRN stock on 01/29/2021 at the average price of $82.79. The price of the stock has decreased by 2.09% since.

• CEO Jean Jacques Bienaime sold 8,333 shares of BMRN stock on 01/27/2021 at the average price of $85.49. The price of the stock has decreased by 5.18% since.

Directors and Officers Recent Trades:

• Director V Bryan Lawlis sold 7,500 shares of BMRN stock on 02/16/2021 at the average price of $87.41. The price of the stock has decreased by 7.26% since.

For the complete insider trading history of BMRN, click here

.This article first appeared on GuruFocus.